These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 6088042
41. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay. Pompecki R, Shively JE, Todd CW. Cancer Res; 1981 May; 41(5):1910-5. PubMed ID: 6163531 [Abstract] [Full Text] [Related]
42. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Klug TL, Bast RC, Niloff JM, Knapp RC, Zurawski VR. Cancer Res; 1984 Mar; 44(3):1048-53. PubMed ID: 6198078 [Abstract] [Full Text] [Related]
43. Frequency of association of mammary tumor glycoprotein antigen and other markers with human breast tumors. Leung JP, Bordin GM, Nakamura RM, DeHeer DH, Edgington TS. Cancer Res; 1979 Jun; 39(6 Pt 1):2057-61. PubMed ID: 221100 [No Abstract] [Full Text] [Related]
44. Peanut lectin agglutinin and alpha-lactalbumin. Binding and immunohistochemical localization in breast tissues. Lloyd RV, Foley J, Judd WJ. Arch Pathol Lab Med; 1984 May; 108(5):392-5. PubMed ID: 6324715 [Abstract] [Full Text] [Related]
45. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas. Ceriani RL, Peterson JA, Blank EW. Cancer Res; 1984 Jul; 44(7):3033-9. PubMed ID: 6144385 [Abstract] [Full Text] [Related]
46. [Identification of a tumor antigen associated to the estrogen receptor in axillary lymph nodes of breast cancer patients]. Laguens G, Di Girolamo V, Spinelli O, Laguens RP. Medicina (B Aires); 1996 Jul; 56(3):269-72. PubMed ID: 9035483 [Abstract] [Full Text] [Related]
47. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma. Holder WD, Wells SA. Cancer Res; 1983 Jan; 43(1):239-44. PubMed ID: 6291754 [Abstract] [Full Text] [Related]
48. MCA performance in preoperative breast cancer patients. Donadeo A, Micelli G, Quaranta M, Atlante A, Schittulli F. Anticancer Res; 1995 Jan; 15(2):527-9. PubMed ID: 7763034 [Abstract] [Full Text] [Related]
49. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, Kato Y, Hirakawa K. Clin Cancer Res; 2000 Oct; 6(10):4069-72. PubMed ID: 11051258 [Abstract] [Full Text] [Related]
50. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas. Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK. Ann Diagn Pathol; 2008 Feb; 12(1):33-40. PubMed ID: 18164413 [Abstract] [Full Text] [Related]
51. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I, Ben-Baruch A. Cancer Res; 1999 Sep 15; 59(18):4681-7. PubMed ID: 10493525 [Abstract] [Full Text] [Related]
52. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach. Tong AW, Lee J, Stone MJ. Cancer Res; 1984 Nov 15; 44(11):4987-92. PubMed ID: 6207911 [Abstract] [Full Text] [Related]
53. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H. Cancer Res; 1982 Nov 15; 42(11):4820-3. PubMed ID: 6751528 [Abstract] [Full Text] [Related]
54. Comparison of rates of phenotypic variability in surface antigen expression in normal and cancerous human breast epithelial cells. Peterson JA, Ceriani RL, Blank EW, Osvaldo L. Cancer Res; 1983 Sep 15; 43(9):4291-6. PubMed ID: 6347369 [Abstract] [Full Text] [Related]
55. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer. Fernández-Madrid F, Tang N, Alansari H, Granda JL, Tait L, Amirikia KC, Moroianu M, Wang X, Karvonen RL. Cancer Res; 2004 Aug 01; 64(15):5089-96. PubMed ID: 15289310 [Abstract] [Full Text] [Related]
56. Monoclonal antibody characterization of a tumor-associated breast cancer antigen. Edwards DP, Dressler LG, Zava DT, McGuire WL. Prog Clin Biol Res; 1986 Aug 01; 204():71-88. PubMed ID: 2421350 [No Abstract] [Full Text] [Related]
57. Decreased expression of galectin-3 is associated with progression of human breast cancer. Castronovo V, Van Den Brûle FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME. J Pathol; 1996 May 01; 179(1):43-8. PubMed ID: 8691344 [Abstract] [Full Text] [Related]
58. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer. Peterson JA, Couto JR, Taylor MR, Ceriani RL. Cancer Res; 1995 Dec 01; 55(23 Suppl):5847s-5851s. PubMed ID: 7493358 [Abstract] [Full Text] [Related]
59. Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients. Lundy J, Thor A, Maenza R, Schlom J, Forouhar F, Testa M, Kufe D. Breast Cancer Res Treat; 1985 Dec 01; 5(3):269-76. PubMed ID: 2992647 [Abstract] [Full Text] [Related]
60. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation. Ioachim E, Kamina S, Demou A, Kontostolis M, Lolis D, Agnantis NJ. Anticancer Res; 1999 Dec 01; 19(3A):2133-9. PubMed ID: 10470161 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]